This finding, coupled with our observation that Cav-1 was significantly elevated in our DNA microarray comparing claudin-low mammary tumors to our primary, IGF-IR induced epithelial mammary tumors led us to examine the expression of Cav-1 in the tumor cells themselves. The gene discussed is CAV1; the disease is neoplasm.